Ginkgo Biloba for Tinnitus | Evidence-Based Guide

Tinnitus — the perception of ringing, buzzing, or other sounds without an external source — affects millions of people worldwide and can significantly impact quality of life. While there is no single cure, research into botanical interventions has drawn considerable attention to Ginkgo Biloba for tinnitus, particularly the standardized leaf extract known as EGb 761.

Ginkgo Biloba is one of the oldest living tree species on Earth, traceable back more than 200 million years. Its medicinal use was first recorded approximately 2,000 years ago in the Chinese Materia Medica Shen Nong Ben Cao Jing, and preparations of Ginkgo Biloba leaves have been used as remedies in China for more than 5,000 years. In modern Western medicine, phytopharmaceutical extracts from ginkgo leaves have been applied to treat cerebrovascular and peripheral vascular diseases in countries such as Germany, France, Japan, and Korea since the 1960s.

The rationale behind using Ginkgo Biloba for tinnitus centers on its well-documented ability to improve blood flow, act as a potent antioxidant, and modulate neurotransmission — mechanisms that may address some of the circulatory and neurological factors thought to contribute to tinnitus.

Research suggests that standardized Ginkgo Biloba extract may offer meaningful support for individuals experiencing tinnitus. There is evidence of efficacy for the standardized extract EGb 761 in the treatment of tinnitus from three trials in patients in whom tinnitus was the primary complaint. Supportive evidence comes from a further five trials in patients with age-associated cognitive impairment or dementia in whom tinnitus was present as a concomitant symptom.

In one randomized, double-blind trial, patients with sub-chronic or chronic tinnitus were randomized to receive 120 mg EGb 761 or 600 mg pentoxifylline, each twice daily in a double-dummy fashion over a 12-week period. For both treatment groups, significant improvements were observed in tinnitus loudness, annoyance, and overall suffering. There was no relevant difference between the two treatment groups — EGb 761 and pentoxifylline were similarly effective, while the incidence of adverse events was lower in the EGb 761 group.

A more recent exploratory multicentre clinical trial examined EGb 761 in chronic tinnitus. At week 24, significant improvements were observed in all tinnitus-related outcomes compared to baseline. Notably, subgroup analyses found that the therapy appears to be particularly beneficial for patients with normal hearing and/or concomitant anxiety and/or stress. Patients with high baseline anxiety or stress improved more, whereas baseline depression had no influence on outcomes. The overall response rate — defined as at least a 30% score reduction in three out of four measured outcomes — was 18.8%.

It is important to note that the efficacy of other ginkgo preparations (beyond EGb 761) has not been proven in tinnitus studies, which does not necessarily indicate ineffectiveness but may be due to flawed clinical trials with non-standardized products.

The mechanisms through which Ginkgo Biloba for tinnitus may exert its effects are multi-faceted, drawing on the extract's broad pharmacological profile:

• Improved circulation: Ginkgo Biloba acts to increase blood flow throughout the body, including to the brain and auditory system. It improves perfusion in different vascular beds without significantly affecting blood pressure and heart rate. Poor microcirculation in the inner ear is considered a contributing factor in some forms of tinnitus.
• Antioxidant protection: The flavonol glycosides in ginkgo are potent free-radical scavengers. This antioxidant activity helps protect neuronal and cardiovascular cells from reactive oxygen species (ROS)-mediated damage, which is especially important for the brain, retina, and cardiovascular system.
• PAF antagonism: Ginkgolide B is the most potent known naturally occurring inhibitor of platelet-activating factor (PAF), a key mediator of inflammation and platelet aggregation. This anti-inflammatory action may reduce tissue ischemia relevant to tinnitus.
• Neuroprotective effects: Ingredients of ginkgo leaves exert appreciable blood-brain barrier-crossing efficacy and neuroprotective activity. EGb 761 has direct effects against necrosis and apoptosis of neurons and improves neural plasticity, as evidenced in vestibular compensation studies.
• Neurotransmitter modulation: Chronic treatment with EGb 761 has been shown to increase dopaminergic transmission in the prefrontal cortex, which may contribute to changes in how the brain processes and perceives auditory signals.

Based on the available evidence, Ginkgo Biloba for tinnitus may be of particular interest to several groups:

• Adults with chronic tinnitus: The clinical trials focused on individuals with sub-chronic or chronic tinnitus, suggesting that this population may see the most relevant benefits from consistent use of standardized Ginkgo Biloba extract.
• Tinnitus sufferers with normal hearing: Subgroup analyses from clinical research found that patients with normacusis (normal hearing) experienced greater improvements in tinnitus-related outcomes.
• Individuals experiencing tinnitus alongside anxiety or stress: Research suggests that patients with high baseline anxiety or stress improved more with Ginkgo Biloba therapy compared to those without these co-occurring conditions.
• Those seeking broader circulatory and cognitive support: Ginkgo Biloba is believed to increase circulation, improve long- and short-term memory, and help concentration, making it a well-rounded supplement for individuals interested in supporting overall brain health alongside tinnitus management.

This product is gluten free, dairy free, soy free, and grain free, making it accessible for individuals with common dietary sensitivities.

Important safety note: Ginkgo Biloba may increase the risk of bleeding in people who are taking anticoagulant drugs such as warfarin. Ginkgo may be unsafe for use during pregnancy. Individuals taking medications should consult a healthcare professional before use.

Take one (1) vegetarian capsule, two (2) times daily with meals.

This product has been standardized under strict European quality standards — comparable to over-the-counter drug standards in the United States — to ensure maximum quality and potency. Because of the wide variation of ginkgo products on the market, using a standardized extract helps ensure consistent levels of the key active compounds. Each capsule contains 120 mg of standardized Ginkgo Biloba leaf extract in a 50:1 concentrate.